Precision Therapeutics - Top 20 VC deals of 2008

Precision Therapeutics, FierceBiotech top venture capital deals of 2008Comany: Precision Therapeutics
Based: Pittsburgh, PA
Amount: $43.01M

Investors: Adams Capital Management, Quaker BioVentures, Birchmere Ventures, Longitude Capital, TVM Capital, Draper Triangle Ventures

Scoop: Diagnostic company Precision Therapeutics booked up $43 million in a sixth round of funding. The money is being used to expand the development and commercialization of ChemoFx, a lab test that predicts how patient's cancer cells will respond to different chemotherapy agents prior to initiating the treatment.

Precision Therapeutics - Top 20 VC deals of 2008

Suggested Articles

Researchers are studying the retrovirus KoRV-A, which is spreading among koalas, to gain new insights into how DNA evolves.

Shionogi and Hsiri Therapeutics first joined forces last year in a licensing and R&D deal focused on tuberculosis and non-tuberculous lung infections.

The efficacy results suggest the experimental oral therapy, abrocitinib, has a shot at challenging the blockbuster biologic incumbent.